Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine
Zahra Sahraei, Minoosh Shabani, Shervin Shokouhi, Ali Saffaei
International Journal of Antimicrobial Agents, doi:10.1016/j.ijantimicag.2020.105945
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre -including this research content -immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
Declarations Funding: None. Competing Interests: None declared. Ethical Approval: Not required.
References
Gao, Tian, Yang, Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies, Biosci Trends,
doi:10.5582/bst.2020.01047Jorge, Melles, Zhang, Lu, Rai et al., Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines, Arthritis Res Ther,
doi:10.1186/s13075-018-1634-8Lim, Im, Cho, Bae, Klein et al., Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by Plasmodium vivax, Antimicrob Agents Chemother,
doi:10.1128/AAC.00339-08Plantone, Koudriavtseva, Current and future use of chloroquine and hydroxychloroquine in infectious, immune, neoplastic, and neurological diseases: a mini-review, Clin Drug Investig,
doi:10.1007/s40261-018-0656-yRainsford, Parke, Clifford-Rashotte, Kean, Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases, Inflammopharmacology,
doi:10.1007/s10787-015-0239-ySavarino, Boelaert, Cassone, Majori, Cauda, Effects of chloroquine on viral infections: an old drug against today's diseases?, Lancet Infect Dis,
doi:10.1016/s1473-3099(03)00806-5{ 'indexed': {'date-parts': [[2024, 5, 13]], 'date-time': '2024-05-13T12:40:20Z', 'timestamp': 1715604020047},
'reference-count': 9,
'publisher': 'Elsevier BV',
'issue': '4',
'license': [ { 'start': { 'date-parts': [[2020, 4, 1]],
'date-time': '2020-04-01T00:00:00Z',
'timestamp': 1585699200000},
'content-version': 'tdm',
'delay-in-days': 0,
'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}],
'content-domain': { 'domain': [ 'clinicalkey.jp', 'clinicalkey.com', 'clinicalkey.es', 'clinicalkey.com.au',
'clinicalkey.fr', 'elsevier.com', 'sciencedirect.com'],
'crossmark-restriction': True},
'published-print': {'date-parts': [[2020, 4]]},
'DOI': '10.1016/j.ijantimicag.2020.105945',
'type': 'journal-article',
'created': {'date-parts': [[2020, 3, 17]], 'date-time': '2020-03-17T11:08:36Z', 'timestamp': 1584443316000},
'page': '105945',
'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy',
'source': 'Crossref',
'is-referenced-by-count': 158,
'title': 'Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine',
'prefix': '10.1016',
'volume': '55',
'author': [ {'given': 'Zahra', 'family': 'Sahraei', 'sequence': 'first', 'affiliation': []},
{'given': 'Minoosh', 'family': 'Shabani', 'sequence': 'additional', 'affiliation': []},
{'given': 'Shervin', 'family': 'Shokouhi', 'sequence': 'additional', 'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0002-9563-924X',
'authenticated-orcid': False,
'given': 'Ali',
'family': 'Saffaei',
'sequence': 'additional',
'affiliation': []}],
'member': '78',
'reference': [ { 'key': '10.1016/j.ijantimicag.2020.105945_bib0001',
'doi-asserted-by': 'crossref',
'DOI': '10.1016/S1473-3099(20)30119-5',
'article-title': 'Open access epidemiological data from the COVID-19 outbreak',
'author': 'Xu',
'year': '2020',
'journal-title': 'Lancet Infect Dis'},
{ 'key': '10.1016/j.ijantimicag.2020.105945_bib0002',
'doi-asserted-by': 'crossref',
'DOI': '10.1016/j.ijantimicag.2020.105923',
'article-title': 'Chloroquine for the 2019 novel coronavirus SARS-CoV-2',
'author': 'Colson',
'year': '2020',
'journal-title': 'Int J Antimicrob Agents'},
{ 'key': '10.1016/j.ijantimicag.2020.105945_bib0003',
'doi-asserted-by': 'crossref',
'DOI': '10.5582/bst.2020.01047',
'article-title': 'Breakthrough: Chloroquine phosphate has shown apparent efficacy in '
'treatment of COVID-19 associated pneumonia in clinical studies',
'author': 'Gao',
'year': '2020',
'journal-title': 'Biosci Trends'},
{ 'key': '10.1016/j.ijantimicag.2020.105945_bib0004',
'doi-asserted-by': 'crossref',
'first-page': '231',
'DOI': '10.1007/s10787-015-0239-y',
'article-title': 'Therapy and pharmacological properties of hydroxychloroquine and '
'chloroquine in treatment of systemic lupus erythematosus, rheumatoid '
'arthritis and related diseases',
'volume': '23',
'author': 'Rainsford',
'year': '2015',
'journal-title': 'Inflammopharmacology'},
{ 'key': '10.1016/j.ijantimicag.2020.105945_bib0005',
'doi-asserted-by': 'crossref',
'first-page': '722',
'DOI': '10.1016/S1473-3099(03)00806-5',
'article-title': "Effects of chloroquine on viral infections: an old drug against today's "
'diseases?',
'volume': '3',
'author': 'Savarino',
'year': '2003',
'journal-title': 'Lancet Infect Dis'},
{ 'key': '10.1016/j.ijantimicag.2020.105945_bib0006',
'doi-asserted-by': 'crossref',
'first-page': '653',
'DOI': '10.1007/s40261-018-0656-y',
'article-title': 'Current and future use of chloroquine and hydroxychloroquine in '
'infectious, immune, neoplastic, and neurological diseases: a '
'mini-review',
'volume': '38',
'author': 'Plantone',
'year': '2018',
'journal-title': 'Clin Drug Investig'},
{ 'key': '10.1016/j.ijantimicag.2020.105945_bib0007',
'doi-asserted-by': 'crossref',
'first-page': '1468',
'DOI': '10.1128/AAC.00339-08',
'article-title': 'Pharmacokinetics of hydroxychloroquine and its clinical implications in '
'chemoprophylaxis against malaria caused by Plasmodium vivax',
'volume': '53',
'author': 'Lim',
'year': '2009',
'journal-title': 'Antimicrob Agents Chemother'},
{ 'key': '10.1016/j.ijantimicag.2020.105945_bib0008',
'doi-asserted-by': 'crossref',
'first-page': '133',
'DOI': '10.1186/s13075-018-1634-8',
'article-title': 'Hydroxychloroquine prescription trends and predictors for excess dosing '
'per recent ophthalmology guidelines',
'volume': '20',
'author': 'Jorge',
'year': '2018',
'journal-title': 'Arthritis Res Ther'},
{ 'key': '10.1016/j.ijantimicag.2020.105945_bib0009',
'doi-asserted-by': 'crossref',
'first-page': '143',
'DOI': '10.1016/j.antiviral.2017.11.017',
'article-title': 'An evaluation of chloroquine as a broad-acting antiviral against hand, '
'foot and mouth disease',
'volume': '149',
'author': 'Tan',
'year': '2018',
'journal-title': 'Antiviral Res'}],
'container-title': 'International Journal of Antimicrobial Agents',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0924857920300959?httpAccept=text/xml',
'content-type': 'text/xml',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://api.elsevier.com/content/article/PII:S0924857920300959?httpAccept=text/plain',
'content-type': 'text/plain',
'content-version': 'vor',
'intended-application': 'text-mining'}],
'deposited': { 'date-parts': [[2020, 7, 9]],
'date-time': '2020-07-09T22:39:29Z',
'timestamp': 1594334369000},
'score': 1,
'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0924857920300959'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2020, 4]]},
'references-count': 9,
'journal-issue': {'issue': '4', 'published-print': {'date-parts': [[2020, 4]]}},
'alternative-id': ['S0924857920300959'],
'URL': 'http://dx.doi.org/10.1016/j.ijantimicag.2020.105945',
'relation': {},
'ISSN': ['0924-8579'],
'subject': [],
'container-title-short': 'International Journal of Antimicrobial Agents',
'published': {'date-parts': [[2020, 4]]},
'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'},
{ 'value': 'Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or '
'hydroxychloroquine',
'name': 'articletitle',
'label': 'Article Title'},
{ 'value': 'International Journal of Antimicrobial Agents',
'name': 'journaltitle',
'label': 'Journal Title'},
{ 'value': 'https://doi.org/10.1016/j.ijantimicag.2020.105945',
'name': 'articlelink',
'label': 'CrossRef DOI link to publisher maintained version'},
{'value': 'article', 'name': 'content_type', 'label': 'Content Type'},
{ 'value': '© 2020 Elsevier B.V. and International Society of Chemotherapy. All rights '
'reserved.',
'name': 'copyright',
'label': 'Copyright'}],
'article-number': '105945'}
